← 產業報告目錄
Commercial Aquaculture Vaccines Market Size, Share & Trends Analysis Report By Pathogen Types (Bacteria and Viruses), Fish Species (Salmon, Tilapia, Bream, Labris Bergylta, Cyprinus Carpio, Sea Bass, Trout, and Cyclopterus Lumpur), End-Users, Region, And Segment Forecasts, 2023-2031
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-03-20頁數 190報告編號 INSIGHTACE-e0665a2d58
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
The Commercial Aquaculture Vaccines Market is positioned for steady expansion, with a projected CAGR of 7.3% from 2025 to 2034.
The Commercial Aquaculture Vaccines sector involves key industry insights & findings from the report:
The mounting consumption of seafood and the rising need for efficient disease management in intensive aquaculture systems boost the demand for vacc. This domain has witnessed pronounced transformation owing to technological breakthroughs and shifting healthcare dynamics.
Several factors contribute to this trajectory, including heightened interest in next-generation products, expanding applications across diverse end-use sectors, and supportive government initiatives.
The market landscape is structured across several key segments—spanning type, application, distribution channel, and region—each contributing uniquely to overall market expansion.
Regional dynamics show North America and Europe as established hubs, with the Asia-Pacific region forecasted to deliver the strongest growth trajectory through the forecast period, driven by demographic shifts and policy support.
Competition in this space is characterized by active product development, strategic collaborations, and geographic expansion among both global leaders and specialized niche players.
The research provides an in-depth evaluation of market forces, competitive positioning, segmental dynamics, and regional trends, equipping stakeholders with actionable intelligence for the forecast period.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Commercial Aquaculture Vaccines Market Snapshot
Chapter 4. Global Commercial Aquaculture Vaccines Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Industry Analysis – Porter's Five Forces Analysis
4.6. Competitive Landscape & Market Share Analysis
4.7. COVID 19 Impact Analysis
Chapter 5. Market Segmentation 1: By Pathogen Types, Estimates & Trend Analysis
5.1. By Pathogen Types, & Market Share, 2024 & 2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Pathogen Types:
5.2.1. Bacteria
5.2.2. Virus
Chapter 6. Market Segmentation 2: By Fish Species Estimates & Trend Analysis
6.1. By Fish Species & Market Share, 2024 & 2034
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Fish Species:
6.2.1. Salmon
6.2.2. Tilapia
6.2.3. Bream
6.2.4. Labris Bergylta
6.2.5. Cyprinus Carpio
6.2.6. Sea Bass
6.2.7. Trout
6.2.8. Cyclopterus Lumpus
Chapter 7. Market Segmentation 2: By End-Users Estimates & Trend Analysis
7.1. By End-Users & Market Share, 2024 & 2034
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By End-Users:
7.2.1. Fish Farming companies
7.2.2. Aquatic research institute
Chapter 8. Commercial Aquaculture Vaccines Market Segmentation 3: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Commercial Aquaculture Vaccines Market revenue (US$ Million) estimates and forecasts By Pathogen Types, 2021 - 2034
8.1.2. North America Commercial Aquaculture Vaccines Market revenue (US$ Million) estimates and forecasts By Fish Species, 2021 - 2034
8.1.3. North America Commercial Aquaculture Vaccines Market revenue (US$ Million) estimates and forecasts By End-Users, 2021 - 2034
8.1.4. North America Commercial Aquaculture Vaccines Market revenue (US$ Million) estimates and forecasts by country, 2021 - 2034
8.2. Europe
8.2.1. Europe Commercial Aquaculture Vaccines Market revenue (US$ Million) By Pathogen Types, 2021 - 2034
8.2.2. Europe Commercial Aquaculture Vaccines Market revenue (US$ Million) By Fish Species, 2021 - 2034
8.2.3. Europe Commercial Aquaculture Vaccines Market revenue (US$ Million) By End-Users, 2021 - 2034
8.2.4. Europe Commercial Aquaculture Vaccines Market revenue (US$ Million) by country, 2021 - 2034
8.3. Asia Pacific
8.3.1. Asia Pacific Commercial Aquaculture Vaccines Market revenue (US$ Million) By Pathogen Types, 2021 - 2034
8.3.2. Asia Pacific Commercial Aquaculture Vaccines Market revenue (US$ Million) By Fish Species, 2021 - 2034
8.3.3. Asia Pacific Commercial Aquaculture Vaccines Market revenue (US$ Million) By End-Users, 2021 - 2034
8.3.4. Asia Pacific Commercial Aquaculture Vaccines Market revenue (US$ Million) by country, 2021 - 2034
8.4. Latin America
8.4.1. Latin America Commercial Aquaculture Vaccines Market revenue (US$ Million) By Pathogen Types, (US$ Million)
8.4.2. Latin America Commercial Aquaculture Vaccines Market revenue (US$ Million) By Fish Species, (US$ Million)
8.4.3. Latin America Commercial Aquaculture Vaccines Market revenue (US$ Million) By End-Users, (US$ Million)
8.4.4. Latin America Commercial Aquaculture Vaccines Market revenue (US$ Million) by country, (US$ Million) 2021 - 2034
8.5. Middle East & Africa
8.5.1. Middle East & Africa Commercial Aquaculture Vaccines Market revenue (US$ Million) By Pathogen Types, (US$ Million)
8.5.2. Middle East & Africa Commercial Aquaculture Vaccines Market revenue (US$ Million) By Fish Species, (US$ Million)
8.5.3. Middle East & Africa Commercial Aquaculture Vaccines Market revenue (US$ Million) By End-Users, (US$ Million)
8.5.4. Middle East & Africa Commercial Aquaculture Vaccines Market revenue (US$ Million) by country, (US$ Million) 2021 - 2034
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. IDT Biologika GmbH (Ridgeway Biologicals Ltd)
9.2.2. MARINNOVAC (AQUATRECK ANIMAL HEALTH S.L.)
9.2.3. Ceva Biovac
9.2.4. Zoetis (PHARMAQAS)
9.2.5. Vaxxinova
9.2.6. Barramundi Asia Pte Ltd.(UVAXX Asia)
9.2.7. HIPRA
9.2.8. AniCon Labor GmbH
9.2.9. sanphar (ipeve)
9.2.10. Kennebec River Biosciences
9.2.11. Merck & Co. Inc.
9.2.12. Tecnovax
9.2.13. HIPRA
9.2.14. Virbac
9.2.15. Veterquimica S.A.
9.2.16. FeedVAX
9.2.17. KoVax (Phibro Animal Health)
9.2.18. Nisseiken Co., Ltd.
9.2.19. Other Prominent Player
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們